Unusual Options Activity Insight: GlaxoSmithKline
Shares of GlaxoSmithKline (NYSE:GSK) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved up to $40.63.
Natera Reports Use Of Signatera As Companion Diagnostic In GlaxoSmithKline’s Phase 3 ZEST Trial For Niraparib In Early-Stage Breast Cancer
-- Natera, Inc. (NASDAQ:NTRA), a pioneer and global leader in cell-free DNA testing, announced that the first patient has been screened in a new phase III trial that uses its personalized, tumor-informed molecular
Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington’s Viola
BioHarvest Sciences Appoints Two Law Firms To Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products
Barron’s Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More
This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge.
Other featured articles discuss how to find rising dividends, why some electric vehicle start-ups are in trouble and whether the shine is off big tech stocks after earnings.
Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia Patients
Alector Inc (NASDAQ: ALEC)
Unusual Options Activity Insight: GlaxoSmithKline
On Monday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved down to $39.13.
Analyzing GlaxoSmithKline’s Unusual Options Activity
On Wednesday, shares of GlaxoSmithKline (NYSE:GSK) saw unusual options activity. After the option alert, the stock price moved up to $39.33.
EMA Starts Rolling Review Of Glaxo – Sanofi COVID-19 Vaccine
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ:
GlaxoSmithKline’s Anemia Candidate Shows Promise In Late-Stage Studies
GlaxoSmithKline Plc (NYSE:GSK) said its anemia drug for patients with chronic kidney disease succeeded in five late-stage trials. The drug, daprodustat,…